DIA 2013
49th Annual Meeting

Advancing Therapeutic Innovation and
Regulatory Science
June 23-27 | Boston, Massachusetts
Boston Convention and Exhibition Center

facebook linked-in twitter youtube Pinterest Flickr

GO DIA 2013 Highlights

Take a Sneak Peak...



Cooperation Among
Regulators: Impact on Stakeholders


Big Data: Impact on Innovation


Advancing Alzheimer’s
Innovation: A Call to Action

CDER Town Hall:
Part 1 of 2

   Where Research, Medicine and Care Converge: A CMO Roundtable Discussion    


Monday, June 24 | Tuesday, June 25 | Wednesday, June 26

DIA 49th Annual Meeting Session Reports

Monday, June 24

View Session 119. Hot Topics in Statistics: Working Together Effectively to Transform Our Science

View Session 123. How Can Translational Medicine Fill The Gaps in Life Sciences Industries?

View Session 130. Translational Aspects from Preclinical Animal Toxicology Studies to Early Human Health Risk Assessment: Needs and Limitations

View Session 143. Key Multiplicity Issues in Clinical Trial

View Session 144. The Secret of Stellar Careers: Serendipity + Planning = Success

Tuesday, June 25

View Session 220. Biomarkers for Drug Development: How are we dealing with the challenges?

View Session 234. Strategies for the Development and Registration of Antibody Drug Conjugates

View Session 239. Student Forum: Getting a Job & Developing a Career 

View Session 262. First-in-Human Studies: How Much Complexity Is Too Much?

View Session 277. Short Breakthrough Status

Wednesday, June 26

View Session 318. Molecular Predictors of Drug Induced Harm: From Clinical Development to Postmarketing Surveillance

View Session 332. Pharmacometrics: Implications and Impact in Preclinical to Early Phase Development

View Session 339. Drug Shortages: Causes, Current State & Path Forward

View Session 343. Challenges and Strategic Approaches to Biosimilar Development

View Session 360. Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market

View Annual Meeting Student Reflections

EMA Press Release: Pharmacovigilance Risk Assessment Committee: One year of Public Health Promotion and Protection

From the News

DIA panel discusses collaboration to improve drug trials by Don Sieffert, Boston Business Journal

Here are 9 industry insiders at DIA 2013 to follow on Twitter by Stephanie Baum, MedCity News

Backlog to the Future: DIA 2013 in pictures
by Gareth Macdonald

Final Count for One Fund Boston Contributions - Thank you DIA Attendees!

DIA 2013 Boston Recap from the BioClinica Exhibit by Jennifer Price

Delegation from Taiwan for the DIA 2013 49th Annual Meeting

49th Annual DIA Meeting Boston

Show Daily

Issue #1 Issue #2 Issue #3 Issue #4

Access Presentations



Unable to Attend DIA 2013 49th Annual Meeting?

Purchase live recordings from this year’s Annual Meeting.

DIA 2013 49th Annual Meeting Photo Library

Tribute to Boston at the DIA 2013 49th Annual Meeting

GO Access Meeting Presentations

The Education You Need • The Resource You Trust

More than 250 educational offerings over 22 tracks on hot topics from key thoughts leaders from the life sciences industry.

Unable to Attend this Year’s Annual Meeting?
Now is your opportunity to listen to global thought leaders involved in the discovery, development, and life cycle management of medical products. Purchase the live recordings from this year’s program NOW for $699 and access the recordings until July 9, 2014.



Attended the Annual Meeting?
Full conference attendees will have access to presentations and session recordings at no additional cost until September 6, 2013.  To extend access until July 9, 2014, purchase the Premium Upgrade at the discounted attendee rate of $549.



  • View available recorded presentations captured on your computer or mobile device
  • Download available offerings in MP3 format to your mobile device for portable listening
  • Search the DIA 2013 49th Annual Meeting program.

Note: Continuing education credits are not available for archived content accessed through DIA's Live Learning Center.

GO Twitter Feed


GO Poster Program Results

Professional Posters

Poster Program 1862

     Poster Program 578
We like to take the opportunity to thank the 60+ Professional Poster Presenters that presented their work in this year’s Annual Meeting Program.

Read Professional Poster abstracts from this year’s Annual Meeting Program included in the next issue of the Global Forum

New this year, Annual Meeting Attendees were asked to select the top 3 Professional Posters from this year’s program.  

Results are in! Congratulations to those selected!

1st place
Current Scenario of Clinical Research Sites in Thailand: A Ground Up Approach to Clinical Site Selection in Emerging Countries
Lisa Maire Saldanha
Director- Feasibility & Site Identification (South East Asia, Korea, ANZ)

Quintiles East Asia Pte. Ltd., Singapore

2nd place
Inspections: Streamlining Backstage Operations Using the Cloud
Suvarna Lakshmi Jetti
Project Manager
Genentech, A Member of the Roche Group

3rd place
Anxiolytic-like Effect of Beta Receptor Agonist Amibegron May be Related to Interaction of Serotonin Receptor Subtypes
Pelin Tanyeri, MD
Assistant Professor
Sakarya University Medical Faculty, Turkey

View Professional Posters from this year’s Annual Meeting Program

Student Poster

Poster Program 585 

Twenty students from all of the world joined us in Boston to present their original research in this year’s program. Student Poster winners (1st, 2nd and 3rd place winners) were announced and recognized on Monday, June 24, please join us in congratulating this year’s student poster presenters!

1st Place:
Evaluation of Cytochrome P450 2C19 Activity in Normal, Healthy Adult Subjects in a Western Indian Population
Harshavardhan Narendra Sant

Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai, Maharashtra, India

2nd Place:
Challenges in Discovery and Development of Orphan Drugs and Possible Solutions: Indian Scenario
Priti Padmakar Pednekar MPharm,
Bharati Vidyapeeth's College of Pharmacy, University of Mumbai, India

3rd Place:
The Registration of Biosimilar Medicines: The Case of Low Molecular Weight Heparines in View of the New CHMP Guideline
Anna Magdalena Perelka
Medical University of Warsaw, Poland

© 2018 DIA